252 related articles for article (PubMed ID: 20071340)
21. Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons.
Pallo SP; Johnson GV
Neurosci Lett; 2015 Jun; 597():32-7. PubMed ID: 25888814
[TBL] [Abstract][Full Text] [Related]
22. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
[TBL] [Abstract][Full Text] [Related]
23. Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and Aβ1-42 gene transfer models.
Hebron ML; Algarzae NK; Lonskaya I; Moussa C
Exp Neurol; 2014 Jan; 251():127-38. PubMed ID: 23333589
[TBL] [Abstract][Full Text] [Related]
24. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
25. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
26. APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice.
Zhou M; Huang T; Collins N; Zhang J; Shen H; Dai X; Xiao N; Wu X; Wei Z; York J; Lin L; Zhu Y; LaDu MJ; Chen X
Curr Alzheimer Res; 2016; 13(9):1048-55. PubMed ID: 27087442
[TBL] [Abstract][Full Text] [Related]
27. Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.
Moussa CE
J Mol Neurosci; 2009 Jan; 37(1):25-36. PubMed ID: 18561034
[TBL] [Abstract][Full Text] [Related]
28. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.
Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L
J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821
[TBL] [Abstract][Full Text] [Related]
29. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
30. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.
Modi KK; Jana A; Ghosh S; Watson R; Pahan K
PLoS One; 2014; 9(8):e103606. PubMed ID: 25089827
[TBL] [Abstract][Full Text] [Related]
31. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
33. Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response.
Magrané J; Rosen KM; Smith RC; Walsh K; Gouras GK; Querfurth HW
J Neurosci; 2005 Nov; 25(47):10960-9. PubMed ID: 16306409
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.
Lloret A; Badia MC; Giraldo E; Ermak G; Alonso MD; Pallardó FV; Davies KJ; Viña J
J Alzheimers Dis; 2011; 27(4):701-9. PubMed ID: 21876249
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
Orellana DI; Quintanilla RA; Maccioni RB
Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism.
Ryan SD; Whitehead SN; Swayne LA; Moffat TC; Hou W; Ethier M; Bourgeois AJ; Rashidian J; Blanchard AP; Fraser PE; Park DS; Figeys D; Bennett SA
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20936-41. PubMed ID: 19926863
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
38. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
[TBL] [Abstract][Full Text] [Related]
39. Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons.
Wei Z; Song MS; MacTavish D; Jhamandas JH; Kar S
Neuropharmacology; 2008 Mar; 54(4):721-33. PubMed ID: 18222494
[TBL] [Abstract][Full Text] [Related]
40. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Hernandez P; Lee G; Sjoberg M; Maccioni RB
J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
